Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions

MP McGinley, JA Cohen - The Lancet, 2021 - thelancet.com
Summary The sphingosine 1-phosphate (S1P) signalling pathways have important and
diverse functions. S1P receptors (S1PRs) have been proposed as a therapeutic target for …

An update on the use of sphingosine 1-phosphate receptor modulators for the treatment of relapsing multiple sclerosis

L Dumitrescu, A Papathanasiou, C Coclitu… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction Multiple sclerosis (MS) is an immune-mediated disorder of the CNS manifested
by recurrent attacks of neurological symptoms (related to focal inflammation) and gradual …

Identification of potential therapeutic targets and mechanisms of COVID-19 through network analysis and screening of chemicals and herbal ingredients

H Wang, J Zhang, Z Lu, W Dai, C Ma… - Briefings in …, 2022 - academic.oup.com
After experiencing the COVID-19 pandemic, it is widely acknowledged that a rapid drug
repurposing method is highly needed. A series of useful drug repurposing tools have been …

Sphingolipids: effectors and Achilles heals in viral infections?

S Schneider-Schaulies, F Schumacher, D Wigger… - Cells, 2021 - mdpi.com
As viruses are obligatory intracellular parasites, any step during their life cycle strictly
depends on successful interaction with their particular host cells. In particular, their …

Limited impact of fingolimod treatment during the initial weeks of ART in SIV-infected rhesus macaques

M Pino, A Pagliuzza, MB Pampena, C Deleage… - Nature …, 2022 - nature.com
Antiretroviral therapy (ART) is not curative due to the persistence of a reservoir of HIV-
infected cells, particularly in tissues such as lymph nodes, with the potential to cause viral …

Immunosenescence and its related comorbidities in older people living with HIV

XY He, XW Wang, S Li, N Li, W Li, Y Hu… - Infectious Diseases & …, 2025 - mednexus.org
With the aging of the global population, older people living with HIV (OPLWH) have
emerged as a focal point in HIV/AIDS research. Although antiretroviral therapy has …

People with HIV have higher percentages of circulating CCR5+ CD8+ T cells and lower percentages of CCR5+ regulatory T cells

LE van Eekeren, V Matzaraki, Z Zhang… - Scientific Reports, 2022 - nature.com
CCR5 is the main HIV co-receptor. We aimed to (1) compare CCR5 expression on immune
cells between people living with HIV (PLHIV) using combination antiretroviral therapy …

The Intact Noninducible Latent HIV-1 Reservoir Is Established in an In Vitro Primary TCM Cell Model of Latency

I Sarabia, SH Huang, AR Ward, RB Jones… - Journal of …, 2021 - Am Soc Microbiol
The establishment of HIV-1 latency has hindered an HIV-1 cure.“Shock and kill” strategies to
target this reservoir aim to induce the latent provirus with latency-reversing agents (LRAs) …

Pharmacological targeting of sphingosine kinases impedes HIV-1 infection of CD4 T cells through SAMHD1 modulation

RS Resop, A Bosque - Journal of virology, 2022 - Am Soc Microbiol
ABSTRACT Sphingosine-1-phosphate (S1P) is a sphingolipid modulator of a myriad of
cellular processes, and therapeutic targeting of S1P signaling is utilized clinically to treat …

[HTML][HTML] Exploring SK/S1P/S1PR pathway as a target for antiviral drug development

SP Swain, CS Mahanta, M Maurya, D Mandal… - Health Sciences …, 2024 - Elsevier
Lysophospholipids are a class of simple phospholipids that shows their biological effects
through various G protein-coupled receptors (GPCRs). Sphingosine 1-phosphate (S1P) is …